Clinical Trials

Esophageal Squamous Cell Carcinoma

NCT07284836 2025-12-16

Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy

Phase 2 Recruiting

30 enrolled

Breast

Hepatic Artery Infusion

NCT05880082 2025-08-24

PPIO-004-EC001

118 enrolled

Phase 2 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT06953323 2025-08-13

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Phase 1/2 Recruiting

86 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Phase 2 Not yet recruiting

Esophageal Neoplasms

NCT07019181 2025-06-13

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

26 enrolled

Esophageal Neoplasms

NCT06775275 2025-01-15

A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

Phase 2 Recruiting

Resectable Lung Non-Small Cell Carcinoma

NCT02776163 2024-07-30

Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas

107 enrolled

Phase 2 Not yet recruiting

Head and Neck Neoplasms

NCT06508229 2024-07-18

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

65 enrolled

Esophageal Squamous Cell Carcinoma

NCT05860335 2024-02-20

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

30 enrolled

Hypopharyngeal Neoplasms

NCT04844385 2024-02-09

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

124 enrolled

Esophageal Squamous Cell Carcinoma

NCT05515315 2024-02-07

Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma

Phase 2 Recruiting

93 enrolled

Immunotherapy Esophagus Cancer

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06102395 2023-10-30

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC

Phase 3 Recruiting

272 enrolled

Phase 1/2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06010212 2023-08-24

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

36 enrolled

Esophageal Squamous Cell Carcinoma

NCT02350517 2023-02-16

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

52 enrolled

Esophageal Squamous Cell Carcinoma

NCT05648071 2022-12-13

SPBPDC

Thoracic

Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT05351762 2022-07-05

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

55 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04437329 2022-05-10

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Phase 3 Recruiting

352 enrolled

Nasopharyngeal Carcinoma

NCT04834206 2022-05-10

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

32 enrolled

Nasopharyngeal Carcinoma

NCT02964455 2020-05-15

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Phase 1 Completed

12 enrolled

Esophageal Squamous Cell Carcinoma

NCT02279134 2020-04-03

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

Phase 2/3 Unknown

360 enrolled

Esophageal Neoplasms

NCT03603756 2020-02-11

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

45 enrolled

Esophageal Squamous Cell Carcinoma

NCT02789189 2019-09-06

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Phase 2 Terminated

Nasopharyngeal Carcinoma, Recurrence

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

Esophageal Neoplasms

NCT03649945 2018-08-28

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

186 enrolled

Phase 3 Not yet recruiting

Esophageal Neoplasms

NCT03503136 2018-05-11

NX-NPC

632 enrolled

Nasopharyngeal Carcinoma

NCT02590133 2017-12-22

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

328 enrolled

Nasopharyngeal Carcinoma

NCT02777788 2017-10-10

TCM

Phase 2/3 Unknown

Tumor-Agnostic

Neoplasms

NCT02088515 2017-03-03

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Phase 4 Completed

290 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT01540136 2016-10-28

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Phase 3 Completed

402 enrolled

Nasopharyngeal Carcinoma

NCT02861690 2016-08-10

Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma

72 enrolled

Esophageal Neoplasms

NCT02835404 2016-07-18

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

200 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02643407 2015-12-31

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

488 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT02537925 2015-09-02

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

NCT01694576 2015-06-15

NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

Phase 2 Terminated

10 enrolled

Nasopharyngeal Carcinoma

NCT02301208 2014-12-08

NPC-RCT-WCRT

Nasopharyngeal Carcinoma

NCT01712919 2014-03-24

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

Phase 1/2 Completed

61 enrolled

Nasopharyngeal Carcinoma

NCT01667211 2012-08-22

CSAPPPCC

30 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01175460 2012-03-06

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Phase 1 Completed

15 enrolled

Esophageal Neoplasms

NCT01479504 2011-11-28

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

2 enrolled

Nasopharyngeal Carcinoma

NCT01265147 2011-01-20

Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma

20 enrolled

Nasopharyngeal Carcinoma

NCT01201044 2010-09-14

DO201001

Phase NA Unknown

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00197444 2009-02-20

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer

33 enrolled